BioSpace News Archive

Amgen announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors.

The collaborative partnership is part of a multi-year effort to advance the nephrology nursing profession

Ipsen and Servier announced initial safety and efficacy data from Part 1 of the Phase II/III RESILIENT study of investigational liposomal irinotecan in patients with small cell lung cancer who progressed following a first-line platinum-based regimen.

Mentorship, feedback and team work among pillars of Company’s vibrant workplace

Aridis Pharmaceuticals, Inc. announced that Vu Truong, Ph.D., Chief Executive Officer, will present at the H.C. Wainwright 21st Annual Global Investment Conference.

Former Ogilvy and WPP executive, David Mayo has joined Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, as Group Sales and Marketing Director.

Todos Medical Ltd. announced that the Company has entered into a non-binding Memorandum of Understanding with Orot+, the operational division of Orot-Luces, to expand their existing launch and distribution partnership for the commercial sale of Todos’ early breast cancer detection blood tests TM-B1 and TM-B2 into Japan.

Crescendo Biologics Ltd announces that Stewart Kay has been appointed as the Company’s Chief Business Officer.

BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator.

Aug. 26, faculty from Tuskegee University traveled to Union Springs, Alabama, with a message of hope for women ranging from middle-school age to adulthood — hope, and real preventative measures for falling victim to cervical cancer.